Chemical Compound
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, (6R,7R)- (9CI); 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6a,7ss(R*)]]-; Bergacef; Cedol; Cefam; Cefamandole formate sodium; Cefamandole nafate; Cefiran; Cemado; Cemandil; Cephamandole nafate; Fado; Kefadol; Kefandol; Lampomandol; Mandokef; Mandol; Mandolsan; NSC 299588; Neocefal; O-Formylcefamandole sodium; Pavecef; Sodium 7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate; Sodium
CAS Registry Number
42540-40-9
Primary record
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, (6R,7R)- (9CI); 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6a,7ss(R*)]]-; Bergacef; Cedol; Cefam; Cefamandole formate sodium; Cefamandole nafate; Cefiran; Cemado; Cemandil; Cephamandole nafate; Fado; Kefadol; Kefandol; Lampomandol; Mandokef; Mandol; Mandolsan; NSC 299588; Neocefal; O-Formylcefamandole sodium; Pavecef; Sodium 7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate; Sodium
- 库存
- 4,117 克
- 纯度
- 98.4 %
- CAS
- 42540-40-9
化合物标识与属性
- CAS
- 42540-40-9
- PubChem CID
- 23665731
- SMILES
- CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)OC=O)SC2)C(=O)[O-].[Na+]
- Canonical SMILES
- Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1.[Na+]
名称与同义词
- cefamandole nafate
- Mandol
- Cephamandole nafate
- Bergacef
- Cedol
- Cefamandol nafato
- Mandolsan
- Mandokef
- Kefadol
- Cefam
- Cefaseptolo
- Lampomandol
- 42540-40-9
- Cemandil
- Neocefal
- Pavecef
- Cemandil Sodium
- cemandil sodium salt
- Kefandol
- cephadole nafate
- CefamandoleNafate
- Cemandilsodiumsalt
- Cefamandole Nafate sodium
- O-Formylcefamandole sodium
- Sodium O-formylcefamandole
- Mandol (TN)
- Cefamandole (nafate)
- Lilly 106223
- Cefamandole nafate CRS
- RefChem:57266
- Cefamandole nafate [USAN]
- Cefamandol nafato [Spanish]
- 8HDO7941DO
- UNII-8HDO7941DO
- Cefamandole nafate, 97%
- Cefamandole nafate (USP)
- DTXSID2022751
- C19H17N6NaO6S2
- Cefamandole formate sodium salt
- CHEBI:3481
- DTXCID502751
- CHEMBL1618
- MFCD00864877
- SCHEMBL181311
- C19H18N6O6S2.Na
- orb1302386
- CEFAMANDOLE NAFATE [MI]
- NSC-299588
- EINECS 255-877-4
- ERK5-4C13
- CEFAMANDOLE NAFATE [VANDF]
- CEFAMANDOLE NAFATE [MART.]
- NSC 299588
- CEFAMANDOLE NAFATE [USP-RS]
- CEFAMANDOLE NAFATE [WHO-DD]
- HY-B1166
- MSK12031
- Tox21_113487
- BBF-00709
- NSC299588
- Cefamandole nafate [USAN:USP:INN:BAN]
- AKOS015895550
- AKOS015961133
- C19-H18-N6-O6-S2.Na
- AC-1642
- CCG-269787
- CID5284526
- CS-4768
- EBC-101066
- FC19846
- GS-3575
- CEFAMANDOLE NAFATE [ORANGE BOOK]
- CEFAMANDOLE NAFATE [EP MONOGRAPH]
- CEFAMANDOLE NAFATE [USP IMPURITY]
- NCGC00183035-01
- AN-14750
- AS-12360
- BC205717
- CID:23665731
- SID:134223487
- CAS-42540-40-9
- NS00089630
- Cefamandole formate sodium;Cephamandole nafate
- C08102
- D00909
- A825931
- C012810
- EN300-25025857
- 42540-40-9, 34444-01-4 [cefamandole]
- I06-1094
- Sodium (6R,7R)-7-(R)-mandelamido-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate formate (ester)
- Q27106102
- Z3041521791
- cefamandole nafate, monosodium salt, (6R-(6alpha,7beta(R*)))-isomer
- Sodium (6R,7R)-7-(R)-mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate formate (ester)
- sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- cefamandole nafate, monosodium salt, 14C-labeled, (6R-(6alpha,7beta,(R*)))-isomer
- (6R,7R)-7-[[(2R)-2-(Formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct -2-ene-2-carboxylic acid sodium
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((FORMYLOXY)PHENYLACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, MONOSODIUM SALT, (6R-(6.ALPHA.,7.BETA.(R*)))
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(R*)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, (6R,7R)- (9CI); 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6a,7ss(R*)]]-; Bergacef; Cedol; Cefam; Cefamandole formate sodium; Cefamandole nafate; Cefiran; Cemado; Cemandil; Cephamandole nafate; Fado; Kefadol; Kefandol; Lampomandol; Mandokef; Mandol; Mandolsan; NSC 299588; Neocefal; O-Formylcefamandole sodium; Pavecef; Sodium 7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate; Sodium
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6.alpha.,7.beta.(R*)]]-
- sodium (6R,7R)-7-((R)-2-(formyloxy)-2-phenylacetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenyl-acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Sodium (6R-(6alpha,7beta(R*)))-7-(((formyloxy)phenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- Sodium [6R-[6alpha,7beta(R*)]]-7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium 7beta-[(2R)-2-(formyloxy)-2-phenylacetamido]-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}ceph-3-em-4-carboxylate
- SODIUM(6R,7R)-7-(R)-MANDELAMIDO-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE FORMATE(ESTER)
- sodium;(6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate